Soonchunhyang University
Also known as: Bucheon Hospital, Soonchunhyang University | DEPARTMENT OF PSYCHIATRY SOONCHUNHYANG UNIVERSITY BUCHEOMN HOSPITAL | Pediatric Allergy & Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital | Pyun BokYang | Soonchunhayng Universtiy Seoul Hospital | Soon Chun Hyang Hospital, Seoul, Korea | Soonchunhyang University Buchen Hospital | Soon Chun Hyang University Bucheon Hospital of Korea | Soonchunhyang university Cheonan Hospital | Soonchunhyang University Cheonan Hospital | Soonchunhyang University College of Medicine | Soonchunhyang University Hospital | Soon Chun Hyang University Hospital | Soonchunhyang University Hospital, Choenan, Chungchoengnam-do, Korea, Republic of | Soon Chun Hyang University Hospital, Department of Neurology | Soonchunhyang University Hospital Seoul | Soon Chun Hyang University Hospital , Seoul, Korea | Soonchunhyang University Hospital, Seoul, Korea, Republic of | Soon Chun Hyang Univ. Hospital | Soonchunhyang U Puchun Hospital
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2006Last known activity
Mar 1, 2024
Timeline
1970s
- Jan 1, 1978
Soonchunhyang University— Founded
Drugs by trial phase (83 distinct, 62 trials)
Phase 4 (33 own, 0 via acquisition)
Phase 3 (23 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Arthritis
- Arthritis, Rheumatoid
- Ascites
- Biliary Tract Neoplasms
- Bronchitis
- Bursitis
- Carcinoma
- Carcinoma, Large Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Colorectal Neoplasms
- Coronary Artery Disease
- Crohn Disease
- Dyspepsia
- Dyssomnias
- Esophagitis
- Esophagitis, Peptic
- Essential Hypertension
- Gastritis
- Gastroesophageal Reflux
- Graft vs Host Disease
- Heart Arrest
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypertension
- Hyponatremia
- Influenza, Human
- Ischemia
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Liver Diseases
- Lymphoma
- Lymphoma, Non-Hodgkin
- Myelodysplastic Syndromes
- Myocardial Reperfusion Injury
- Neutropenia
- Osteoarthritis
- Osteoarthritis, Knee
- Out-of-Hospital Cardiac Arrest
- Pancreatic Neoplasms
- Parasomnias
- Parkinson Disease
- Peritonitis
- Psychotic Disorders
- Renal Insufficiency
- Reperfusion Injury
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Schizophrenia
- Sleep Wake Disorders
- Stomach Neoplasms
- Stroke
- Urinary Bladder, Overactive
Recent trials (50)
- NCT06172634Lead sponsorPhase 1/Phase 2Mar 1, 2024
- NCT06172634Reponsible party - principal investigatorPhase 1/Phase 2Mar 1, 2024
- NCT06272630OfficialPhase 4Feb 6, 2023
- NCT05808985Study chairPhase 2Sep 2, 2022
- NCT05808985Lead sponsorPhase 2Sep 2, 2022
- NCT05808985Reponsible party - principal investigatorPhase 2Sep 2, 2022
- NCT05257824CollaboratorPhase 4Jun 23, 2022
- NCT05004324Overall official - principal investigatorPhase 3Jun 29, 2021
- NCT04014803CollaboratorPhase 4Jul 8, 2019
- NCT03990805Overall official - principal investigatorPhase 3Jun 11, 2019
- NCT04479449Overall official - principal investigatorPhase 2Mar 18, 2019
- NCT03651557CollaboratorPhase 2Aug 31, 2018
- NCT03484832Lead sponsorPhase 4Mar 14, 2018
- NCT03484832Overall official - principal investigatorPhase 4Mar 14, 2018
- NCT03484832Reponsible party - principal investigatorPhase 4Mar 14, 2018
Details
- Founded
- Asan, KR Jan 1, 1978
- Last known activity
- Mar 1, 2024